Giovanni B. Ferrara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giovanni B. Ferrara has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
A. Corradi
1 shared publicationA. Rubartelli
1 shared publicationAndrea Bacigalupo
1 shared publicationAndrea Bontadini
1 shared publicationAnna M. Parodi
1 shared publicationAnna Morabito
1 shared publication
Latest Publications
- 15 November 2001
- Published by American Society of Hematology in Blood
- Vol. 98 (10) , 3150-3155
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain
The hypothesis was tested that amino acid substitutions in specific positions within human leukocyte antigen class I heavy chain would have different impacts on transplant-related mortality (TRM) in patients receiving transplanted bone marrow from unrelated donors. One hundred patients and their unrelated donors were typed by sequence-based typing for the human leukocyte antigen (HLA)–A, -B, and -C loci. All pairs were matched for DRB1, DRB3, DRB4, DRB5, DQA1, and DQB1 loci. Forty pairs were also matched at class I, and 60 pairs had one or more mismatches at class I loci. It was found that substitutions at positions 116 and 114 of class I heavy chain significantly increased the risk for TRM in univariate and bivariate Cox analyses. Conversely, no association between number of multiple mismatches or number of amino acid substitutions and TRM was seen when positions 116 and 114 were adjusted for. Variables predictive of TRM in multivariate Cox analysis were number of cells infused, diagnosis (chronic myeloid leukemia [CML] or non-CML), and amino acid substitution at position 116 or 152. The only variable predictive of severe acute graft-versus-host disease (GVHD) in multivariate Cox analysis was substitution at position 116. Actuarial risk for acute GVHD grade III-IV, TRM, and relapse in pairs with substitutions at position 116 (n = 37) compared to other pairs (n = 63) was, respectively, 36% versus 14% (P = .01), 59% versus 28% (P = .001), and 25% versus 31% (P = .4). In conclusion these data suggest that substitutions at position 116 of class I heavy chain increase the risk for acute GVHD and TRM in patients who receive transplanted bone marrow from unrelated donors.
- 15 November 2001
- Published by American Society of Hematology in Blood
- Vol. 98 (10) , 3150-3155
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain
The hypothesis was tested that amino acid substitutions in specific positions within human leukocyte antigen class I heavy chain would have different impacts on transplant-related mortality (TRM) in patients receiving transplanted bone marrow from unrelated donors. One hundred patients and their unrelated donors were typed by sequence-based typing for the human leukocyte antigen (HLA)–A, -B, and -C loci. All pairs were matched for DRB1, DRB3, DRB4, DRB5, DQA1, and DQB1 loci. Forty pairs were also matched at class I, and 60 pairs had one or more mismatches at class I loci. It was found that substitutions at positions 116 and 114 of class I heavy chain significantly increased the risk for TRM in univariate and bivariate Cox analyses. Conversely, no association between number of multiple mismatches or number of amino acid substitutions and TRM was seen when positions 116 and 114 were adjusted for. Variables predictive of TRM in multivariate Cox analysis were number of cells infused, diagnosis (chronic myeloid leukemia [CML] or non-CML), and amino acid substitution at position 116 or 152. The only variable predictive of severe acute graft-versus-host disease (GVHD) in multivariate Cox analysis was substitution at position 116. Actuarial risk for acute GVHD grade III-IV, TRM, and relapse in pairs with substitutions at position 116 (n = 37) compared to other pairs (n = 63) was, respectively, 36% versus 14% (P = .01), 59% versus 28% (P = .001), and 25% versus 31% (P = .4). In conclusion these data suggest that substitutions at position 116 of class I heavy chain increase the risk for acute GVHD and TRM in patients who receive transplanted bone marrow from unrelated donors.
- 31 December 1994
- Published by Elsevier in Human Immunology
- Vol. 40, 81
Activated but not resting CD4+ T cells present via class I A cytosolic peptide derived from IL-1 receptor antagonist protein
- 31 December 1994
- Published by Elsevier in Human Immunology
- Vol. 40, 81
Activated but not resting CD4+ T cells present via class I A cytosolic peptide derived from IL-1 receptor antagonist protein
- 1 April 1987
- Vol. 39 (4) , 225-8
[Breast neoplasms: possible prognostic role of steroid receptors].